Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6941-6947
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6941
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6941
Table 2 Expression of telomerase activity according to the clinicopathological characteristics of 74 esophageal cancer patients
Telomerase (+) | Telomerase (-) | P value1 | |
Gender | 1.0 | ||
Female | 3 | 0 | |
Male | 60 | 11 | |
Differentiation | 0.492 | ||
Well to moderate | 20 | 5 | |
Poor | 43 | 6 | |
Tumor Size | 1.0 | ||
T1+T2 | 11 | 2 | |
T3+T4 | 52 | 9 | |
Lymph node | 0.321 | ||
N0 | 19 | 5 | |
N1 | 44 | 6 | |
Metastasis | 0.11 | ||
M0 | 49 | 11 | |
M1 | 14 | 0 | |
Stage | 0.194 | ||
I+II | 21 | 6 | |
III+IV | 42 | 5 |
- Citation: Hsu CP, Lee LW, Shai SE, Chen CY. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus. World J Gastroenterol 2005; 11(44): 6941-6947
- URL: https://www.wjgnet.com/1007-9327/full/v11/i44/6941.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i44.6941